Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High …

…, J Eikelboom, A Farb, CM Gibson, J Gregson… - Circulation, 2019 - Am Heart Assoc
Identification and management of patients at high bleeding risk undergoing percutaneous
coronary intervention are of major importance, but a lack of standardization in defining this …

Comparison of propensity score methods and covariate adjustment: evaluation in 4 cardiovascular studies

MC Elze, J Gregson, U Baber, E Williamson… - Journal of the American …, 2017 - jacc.org
Propensity scores (PS) are an increasingly popular method to adjust for confounding in
observational studies. Propensity score methods have theoretical advantages over conventional …

[HTML][HTML] HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and …

RK Gupta, J Gregson, N Parkin… - The Lancet infectious …, 2018 - thelancet.com
Background Pretreatment drug resistance in people initiating or re-initiating antiretroviral
therapy (ART) containing non-nucleoside reverse transcriptase inhibitors (NNRTIs) might …

[HTML][HTML] Polymer-free drug-coated coronary stents in patients at high bleeding risk

…, K Oldroyd, R Zambahari, J Gregson… - … England Journal of …, 2015 - Mass Medical Soc
Background Patients at high risk for bleeding who undergo percutaneous coronary intervention
(PCI) often receive bare-metal stents followed by 1 month of dual antiplatelet therapy. …

[HTML][HTML] Five-year outcomes after PCI or CABG for left main coronary disease

…, P Pagé, R Modolo, J Gregson… - … England Journal of …, 2019 - Mass Medical Soc
Background Long-term outcomes after percutaneous coronary intervention (PCI) with
contemporary drug-eluting stents, as compared with coronary-artery bypass grafting (CABG), in …

[HTML][HTML] Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial

…, R Wassall, AS Lota, Z Khalique, J Gregson… - The Lancet, 2019 - thelancet.com
Background Patients with dilated cardiomyopathy whose symptoms and cardiac function have
recovered often ask whether their medications can be stopped. The safety of withdrawing …

BMI and risk of dementia in two million people over two decades: a retrospective cohort study

N Qizilbash, J Gregson, ME Johnson… - The lancet Diabetes & …, 2015 - thelancet.com
Background Dementia and obesity are increasingly important public health issues. Obesity
in middle age has been proposed to lead to dementia in old age. We investigated the …

Prevalence, impact, and predictive value of detecting subclinical coronary and carotid atherosclerosis in asymptomatic adults: the BioImage study

…, P Muntendam, MJ Garcia, J Gregson… - Journal of the American …, 2015 - jacc.org
Background : Although recent studies suggest that measuring coronary artery calcification (CAC)
may be superior to indirect atherosclerotic markers in predicting cardiac risk, there are …

[HTML][HTML] Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global …

…, MR Jordan, BJ Sultan, A Hill, DHJ Davis, J Gregson… - The Lancet, 2012 - thelancet.com
Background The emergence and spread of high levels of HIV-1 drug resistance in resource-limited
settings where combination antiretroviral treatment has been scaled up could …

Environmental toxic metal contaminants and risk of cardiovascular disease: systematic review and meta-analysis

…, S Shahzad, SK Kunutsor, T Muka, J Gregson… - bmj, 2018 - bmj.com
Objective To conduct a systematic review and meta-analysis of epidemiological studies
investigating the association of arsenic, lead, cadmium, mercury, and copper with cardiovascular …